ArticleTexas Heart Institute journal2013

Simvastatin activates the PPARγ-dependent pathway to prevent left ventricular hypertrophy associated with inhibition of RhoA signaling.

Cao Zou et al.PubMed ↗Full text ↗

No numbers read from the abstract.